News and updates with the latest clinical trials, medical reports and interesting developments within the DMD community.
The Phase 1 Open Label Extension and Phase 2 Clinical Trial into Suvodirsen has been terminated on the basis of interim data.
We have placed cookies on your computer to help make this website better. For more information please click here
By continuing to use this site or closing this panel, we'll assume you're OK to continue. You can view our full privacy policy here